NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
19 April 2025
| Name: | JUSTKAPITAL LIMITED (JKL) (This company subsequently changed its name to LAWFINANCE LIMITED. You should refer to that name for Status.) | ||||||||||||||||||
| Date of Listing: | 12 May 2000 | ||||||||||||||||||
| Subsequent Names: |
| ||||||||||||||||||
| Former Names: |
|
Stock Exchange Status: (updated daily)
This company subsequently changed its name to LAWFINANCE LIMITED. You should refer to that name for Stock Exchange Status.Legal Status: (updated monthly)
This company subsequently changed its name to LAWFINANCE LIMITED. You should refer to that name for Legal Status.Capital Gains Tax (CGT) Status: (updated at least quarterly)
This company subsequently changed its name and is now LAWFINANCE LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| LAWFINANCE LIMITED | 31/12/2018 | |
| JUSTKAPITAL LIMITED | 03/02/2017 | 31/12/2018 |
| JUSTKAPITAL LITIGATION PARTNERS LIMITED | 27/02/2015 | 03/02/2017 |
| AFRICAN CHROME FIELDS LIMITED | 28/02/2014 | 27/02/2015 |
| TPL CORPORATION LIMITED | 15/05/2008 | 28/02/2014 |
| TERRAPLANET LIMITED | 06/06/2001 | 15/05/2008 |
| TERRAPLANET.COM LIMITED | 06/06/2001 |
Link Market Services Perth
Level 12 QV1 Building 250 St Georges Terrace Perth WA 6000
Tel : +61 8 9211 6670 or 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail
Expand this box to read and print
name changed to LawFinance Limited | 31/12/2018 |
The securities of JustKapital Limited ("˜JKL') are expected to be reinstated to Official Quotation at the commencement of trading at 10:04:30am AEDT on Wednesday, 2 January 2019. It is expected that, for ASX purposes, the change of name from JustKapital Limited to LawFinance Limited, and the change of code from JKL to LAW, will be effective on Monday, 31 December 2018 | 28/12/2018 |
An additional l 1,264,569 fully paid ordinary shares are due to be released from escrow on 31 December 2018. The total number of restricted securities due to be released from escrow on 31 December 2018 are as follows: 2,695,729 fully paid ordinary shares with release date of 31 December 2018. | 14/12/2018 |
The offer under the cleansing prospectus dated 13 December 2018 has closed, which will result in $8 (before costs) being raised via the issue 100 new shares at an issue price of $0.08 per share. | 13/12/2018 |
The company issues a cleansing prospectus for the offer of 100 Shares at an issue price of $0.08 per New Share to investors, who are invited by the Company to subscribe for New Shares under this Prospectus. | 13/12/2018 |
The following restricted securities are due to be released from escrow on the following date: 1,431,160 - fully paid ordinary shares - release date: 31 December 2018. | 11/12/2018 |
The company releases its mended Constitution. | 19/11/2018 |
The company releases the Results of Meeting. | 15/11/2018 |
The company releases an AGM Presentation. | 15/11/2018 |
The company releases a Corporate Governance Statement. | 01/11/2018 |
The company provides commentary on the Appendix 4C for the quarter ended 30 September 2018. Trading update is as follows: The Australian Net Receivables (net of provisions for doubtful debts and discounts) grew 5.5% to $37.6M and is expected to be collected from our legal firm clients over the next 24 months. An update on National Health Finance - The US Net Receivables (net of provisions for doubtful debts and discounts), as at 30 June 2018, was US$94.9M (A$135.6M) and these are expected to be collected over the next 36-48 months. | 31/10/2018 |
The company lodges an Appendix 4C - quarterly. | 31/10/2018 |
ASX is in the process of reviewing the Company's application for recompliance with Chapters 1 and 2 of the ASX Listing Rules in accordance with ASX Listing Rule 11.1.3. Therefore, the Company's securities will remain suspended until the ASX has confirmed its Recompliance. | 23/10/2018 |
The company's nonrenounceable pro rata rights issue of up to 147,933,598 new ordinary shares in the Company closed at 5pm on Wednesday, 17 October 2018. In line with this, the company releases a notification of under subscriptions. | 22/10/2018 |
The company releases the Open Briefing interview with CEO on Acquisition of NHF. | 15/10/2018 |
The company releases a notice of AGM. The AGM will be held at 10:30am on Thursday 15 November 2018 at Bennelong Room DEXUS Place Level 15, Governor Macquarie Tower 1 Farrer Place Sydney NSW 2000. | 10/10/2018 |
The company releases its Investor Presentation. | 09/10/2018 |
The Company is pleased to advise of its change of name to "˜LawFinance Limited' following approval at the extraordinary meeting of shareholders on 26 September 2018 and the change being recorded on the Australian Securities and Investments Commission's records effective 1 October 2018. The expected effective date for the change to the company's name and ticker code on the ASX platform is 26 October 2018. | 03/10/2018 |
Following strong support from its shareholders at the recent Extraordinary General Meeting, it has successfully closed the acquisition of National Health Finance HoldCo, LLC for US$53m. All conditions precedent to the Transaction were satisfied or waived and the Transaction was completed in the US on 28 September 2018. | 02/10/2018 |
The company provides an updated timetable in respect e non-renounceable pro rata rights issue set out in the prospectus. | 28/09/2018 |
The company sends a letter to its shareholders regarding the non-renounceable pro rata rights issue of up to 147,933,598 Shares, under which each Eligible Shareholder may apply for one New Share for every one Existing Share held by the Eligible Shareholder on the Record Date (being 7.00pm (Sydney time) on 1 October 2018), at an issue price of $0.08 per Share to raise up to approximately A$11.8 million (before costs). | 27/09/2018 |
The company releases the results of its EGM. | 26/09/2018 |
The company has obtained shareholder approval for the acquisition of leading US personal injury financier National Health Finance HoldCo, and that the Company expects to close the transaction on 28 September 2018. The acquisition price of US$53m for the purchase of 100% of NHF will be funded by a combination of cash and JustKapital scrip. The cash component will be funded through a A$42m syndicated loan facility which is expected to settle tomorrow. | 26/09/2018 |
The company issues a prospectus for the offer of one JustKapital New Share for every one JustKapital Existing Share at an issue price of A$0.08 per JustKapital New Share "“ up to 147.93 million new fully paid ordinary shares in JustKapital. The Prospectus Offer is scheduled to close at 5:00pm on 15 October 2018 unless extended or withdrawn. Applications must be received before that time to be valid. | 21/09/2018 |
The company releases an Investor Presentation. | 04/09/2018 |
The company releases an Appendix 4G. | 03/09/2018 |
The company lodges its Appendix 4E and Annual Report. | 31/08/2018 |
The company releases a sample proxy form which will be included with the notice of meeting to be dispatched to shareholders. | 24/08/2018 |
The company despatches a notice of meeting to its shareholders. The EGM will be held at Bligh Room DEXUS Place Level 15, Governor Macquarie Tower 1 Farrer Place Sydney NSW 2000 at 10:00am (Sydney Time) on 26 September 2018. | 24/08/2018 |
Following a scheduled ASX internal system change affecting the Market Announcements Platform, it has been necessary to re-apply the "˜Suspend' session state. This announcement serves to re-confirm the securities of this entity remain suspended. | 06/08/2018 |
The company provides commentary on the Appendix 4C for the quarter ended 30 June 2018 and an update on its trading to 30 June 2018. | 01/08/2018 |
The company lodges its Appendix 4C - June 2018. | 01/08/2018 |
On 18 July 2018, the company entered into 2 conditional Securities Purchase Agreements to acquire a 100% interest in United States personal injury financier National Health Finance HoldCo, LLC for A$68.8m. | 19/07/2018 |
The securities of JustKapital Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of the Company, pending the release of an announcement regarding a proposed acquisition. | 19/07/2018 |
The suspension of trading in the securities of JustKapital Limited will be lifted immediately, following receipt of an announcement by the Company regarding the proposed acquisition of the National Health Finance Business and transfer of the Litigation Funding Portfolio to the Litigation Finance Trust. | 04/12/2017 |
The proposed 70% acquisition of the US personal injury litigation financing business National Health Finance will no longer be pursued in its current structure. Despite the Company's best efforts, JustKapital has been unable to secure sufficient debt and equity funding in a timeframe deemed acceptable since the transaction became public knowledge. The Company will update the market should the transaction be revisited under an alternative structure. The company has reached favourable terms with Mr Philip Kapp resulting in Mr Kapp assuming management rights over the majority of the Group's funded cases which will be transferred into the Litigation Finance Trust. | 04/12/2017 |
The company releases the results of its meeting. | 29/11/2017 |
The company releases its AGM Opening Address. | 29/11/2017 |
The securities of JustKapital Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding the proposed acquisition of the National Health Finance Business and transfer of the Litigation Funding Portfolio to the Litigation Finance Trust. | 22/11/2017 |
The company provides a market update in connection with the acquisition of an interest in National Health Finance. JustKapital will seek shareholder approval of the NHF transaction at its 2017 annual general meeting. Completion of the transaction is subject to several conditions, including commitment of a debt facility, shareholder approval and completion of an equity capital raising. | 20/09/2017 |
The suspension of trading in the securities of JustKapital Limited will be lifted immediately, following receipt of an announcement by the Company regarding its proposed acquisition of the National Health Finance business. | 20/09/2017 |
The company announces governance and remuneration changes. | 18/09/2017 |
The company has received confirmation from ASX that it will not be required to meet afresh the requirements in Chapters 1 and 2 of the Listing Rules in connection with the proposed acquisition of an interest in National Health Finance. | 15/09/2017 |
The company has signed a conditional Securities Purchase Agreement to acquire 70% of National Health Finance. | 12/09/2017 |
The company has not yet received ASX's determination on the application of Chapter 11 of the ASX Listing Rules to the company's proposed acquisition of the National Health Finance business. | 11/09/2017 |
The securities of JustKapital Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a determination by ASX in relation to the application of chapter 11 of the ASX Listing Rules to the Company's proposed acquisition of the National Health Finance business. | 06/09/2017 |
name changed from JustKapital Litigation Partners Limited | 03/02/2017 |
name changed to LawFinance Limited | 31/12/2018 |
The securities of JustKapital Limited ("˜JKL') are expected to be reinstated to Official Quotation at the commencement of trading at 10:04:30am AEDT on Wednesday, 2 January 2019. It is expected that, for ASX purposes, the change of name from JustKapital Limited to LawFinance Limited, and the change of code from JKL to LAW, will be effective on Monday, 31 December 2018 | 28/12/2018 |
An additional l 1,264,569 fully paid ordinary shares are due to be released from escrow on 31 December 2018. The total number of restricted securities due to be released from escrow on 31 December 2018 are as follows: 2,695,729 fully paid ordinary shares with release date of 31 December 2018. | 14/12/2018 |
The offer under the cleansing prospectus dated 13 December 2018 has closed, which will result in $8 (before costs) being raised via the issue 100 new shares at an issue price of $0.08 per share. | 13/12/2018 |
The company issues a cleansing prospectus for the offer of 100 Shares at an issue price of $0.08 per New Share to investors, who are invited by the Company to subscribe for New Shares under this Prospectus. | 13/12/2018 |
The following restricted securities are due to be released from escrow on the following date: 1,431,160 - fully paid ordinary shares - release date: 31 December 2018. | 11/12/2018 |
The company releases its mended Constitution. | 19/11/2018 |
The company releases the Results of Meeting. | 15/11/2018 |
The company releases an AGM Presentation. | 15/11/2018 |
The company releases a Corporate Governance Statement. | 01/11/2018 |
The company provides commentary on the Appendix 4C for the quarter ended 30 September 2018. Trading update is as follows: The Australian Net Receivables (net of provisions for doubtful debts and discounts) grew 5.5% to $37.6M and is expected to be collected from our legal firm clients over the next 24 months. An update on National Health Finance - The US Net Receivables (net of provisions for doubtful debts and discounts), as at 30 June 2018, was US$94.9M (A$135.6M) and these are expected to be collected over the next 36-48 months. | 31/10/2018 |
The company lodges an Appendix 4C - quarterly. | 31/10/2018 |
ASX is in the process of reviewing the Company's application for recompliance with Chapters 1 and 2 of the ASX Listing Rules in accordance with ASX Listing Rule 11.1.3. Therefore, the Company's securities will remain suspended until the ASX has confirmed its Recompliance. | 23/10/2018 |
The company's nonrenounceable pro rata rights issue of up to 147,933,598 new ordinary shares in the Company closed at 5pm on Wednesday, 17 October 2018. In line with this, the company releases a notification of under subscriptions. | 22/10/2018 |
The company releases the Open Briefing interview with CEO on Acquisition of NHF. | 15/10/2018 |
The company releases a notice of AGM. The AGM will be held at 10:30am on Thursday 15 November 2018 at Bennelong Room DEXUS Place Level 15, Governor Macquarie Tower 1 Farrer Place Sydney NSW 2000. | 10/10/2018 |
The company releases its Investor Presentation. | 09/10/2018 |
The Company is pleased to advise of its change of name to "˜LawFinance Limited' following approval at the extraordinary meeting of shareholders on 26 September 2018 and the change being recorded on the Australian Securities and Investments Commission's records effective 1 October 2018. The expected effective date for the change to the company's name and ticker code on the ASX platform is 26 October 2018. | 03/10/2018 |
Following strong support from its shareholders at the recent Extraordinary General Meeting, it has successfully closed the acquisition of National Health Finance HoldCo, LLC for US$53m. All conditions precedent to the Transaction were satisfied or waived and the Transaction was completed in the US on 28 September 2018. | 02/10/2018 |
The company provides an updated timetable in respect e non-renounceable pro rata rights issue set out in the prospectus. | 28/09/2018 |
The company sends a letter to its shareholders regarding the non-renounceable pro rata rights issue of up to 147,933,598 Shares, under which each Eligible Shareholder may apply for one New Share for every one Existing Share held by the Eligible Shareholder on the Record Date (being 7.00pm (Sydney time) on 1 October 2018), at an issue price of $0.08 per Share to raise up to approximately A$11.8 million (before costs). | 27/09/2018 |
The company releases the results of its EGM. | 26/09/2018 |
The company has obtained shareholder approval for the acquisition of leading US personal injury financier National Health Finance HoldCo, and that the Company expects to close the transaction on 28 September 2018. The acquisition price of US$53m for the purchase of 100% of NHF will be funded by a combination of cash and JustKapital scrip. The cash component will be funded through a A$42m syndicated loan facility which is expected to settle tomorrow. | 26/09/2018 |
The company issues a prospectus for the offer of one JustKapital New Share for every one JustKapital Existing Share at an issue price of A$0.08 per JustKapital New Share "“ up to 147.93 million new fully paid ordinary shares in JustKapital. The Prospectus Offer is scheduled to close at 5:00pm on 15 October 2018 unless extended or withdrawn. Applications must be received before that time to be valid. | 21/09/2018 |
The company releases an Investor Presentation. | 04/09/2018 |
The company releases an Appendix 4G. | 03/09/2018 |
The company lodges its Appendix 4E and Annual Report. | 31/08/2018 |
The company releases a sample proxy form which will be included with the notice of meeting to be dispatched to shareholders. | 24/08/2018 |
The company despatches a notice of meeting to its shareholders. The EGM will be held at Bligh Room DEXUS Place Level 15, Governor Macquarie Tower 1 Farrer Place Sydney NSW 2000 at 10:00am (Sydney Time) on 26 September 2018. | 24/08/2018 |
Following a scheduled ASX internal system change affecting the Market Announcements Platform, it has been necessary to re-apply the "˜Suspend' session state. This announcement serves to re-confirm the securities of this entity remain suspended. | 06/08/2018 |
The company provides commentary on the Appendix 4C for the quarter ended 30 June 2018 and an update on its trading to 30 June 2018. | 01/08/2018 |
The company lodges its Appendix 4C - June 2018. | 01/08/2018 |
On 18 July 2018, the company entered into 2 conditional Securities Purchase Agreements to acquire a 100% interest in United States personal injury financier National Health Finance HoldCo, LLC for A$68.8m. | 19/07/2018 |
The securities of JustKapital Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of the Company, pending the release of an announcement regarding a proposed acquisition. | 19/07/2018 |
The suspension of trading in the securities of JustKapital Limited will be lifted immediately, following receipt of an announcement by the Company regarding the proposed acquisition of the National Health Finance Business and transfer of the Litigation Funding Portfolio to the Litigation Finance Trust. | 04/12/2017 |
The proposed 70% acquisition of the US personal injury litigation financing business National Health Finance will no longer be pursued in its current structure. Despite the Company's best efforts, JustKapital has been unable to secure sufficient debt and equity funding in a timeframe deemed acceptable since the transaction became public knowledge. The Company will update the market should the transaction be revisited under an alternative structure. The company has reached favourable terms with Mr Philip Kapp resulting in Mr Kapp assuming management rights over the majority of the Group's funded cases which will be transferred into the Litigation Finance Trust. | 04/12/2017 |
The company releases the results of its meeting. | 29/11/2017 |
The company releases its AGM Opening Address. | 29/11/2017 |
The securities of JustKapital Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding the proposed acquisition of the National Health Finance Business and transfer of the Litigation Funding Portfolio to the Litigation Finance Trust. | 22/11/2017 |
The company provides a market update in connection with the acquisition of an interest in National Health Finance. JustKapital will seek shareholder approval of the NHF transaction at its 2017 annual general meeting. Completion of the transaction is subject to several conditions, including commitment of a debt facility, shareholder approval and completion of an equity capital raising. | 20/09/2017 |
The suspension of trading in the securities of JustKapital Limited will be lifted immediately, following receipt of an announcement by the Company regarding its proposed acquisition of the National Health Finance business. | 20/09/2017 |
The company announces governance and remuneration changes. | 18/09/2017 |
The company has received confirmation from ASX that it will not be required to meet afresh the requirements in Chapters 1 and 2 of the Listing Rules in connection with the proposed acquisition of an interest in National Health Finance. | 15/09/2017 |
The company has signed a conditional Securities Purchase Agreement to acquire 70% of National Health Finance. | 12/09/2017 |
The company has not yet received ASX's determination on the application of Chapter 11 of the ASX Listing Rules to the company's proposed acquisition of the National Health Finance business. | 11/09/2017 |
The securities of JustKapital Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a determination by ASX in relation to the application of chapter 11 of the ASX Listing Rules to the Company's proposed acquisition of the National Health Finance business. | 06/09/2017 |
name changed from JustKapital Litigation Partners Limited | 03/02/2017 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 31/01/2018 | Timothy Storey | 634,955 | $0.079 | $50,346 |
| 25/01/2018 | Diane Jones | 74,637 | $0.077 | $5,747 |
| 16/01/2018 | Diane Jones | 633,363 | $0.086 | $54,298 |
| 12/01/2018 | Anthony Murphy | 85,000 | $0.082 | $6,970 |
| 03/10/2017 | Philip Kapp | 220,000 | $0.183 | $40,300 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Timothy Storey | Non Exec Chairman | 04/08/2014 |
| Anthony Hersch | COO | 27/11/2017 |
| Jonny Allatt | COO | 02/04/2015 |
| Craig Beatton | CFO | 27/11/2017 |
| Anthony Murphy | Non Exec Director | 31/10/2017 |
| David Wattel | Director | 26/09/2018 |
| Diane Jones | Director, CEO | 04/03/2016 |
| Dean Jagger | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Mike Hill | Non Exec Director | 30/03/2015 | 27/11/2017 |
| Philip Kapp | Chairman, Managing Director | 04/08/2014 | 31/10/2017 |
| Hugh Warner | Executive Chairman | 17/05/2010 | 15/01/2016 |
| Harry Greaves | Non Exec Director | 19/08/2013 | 11/02/2015 |
| Neil Hackett | Non Exec Director | 09/06/2011 | 08/08/2014 |
| James Pratt | Director | 28/10/2009 | 28/02/2014 |
| Mark Gunther | Managing Director | 07/06/2010 | 06/02/2012 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
